Spiriva Handihaler/Spiriva Respimat

Spiriva Handihaler/Spiriva Respimat

tiotropium bromide

Manufacturer:

Boehringer Ingelheim

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Tiotropium Br monohydrate
Indications/Uses
Maintenance treatment of patients w/ COPD (including chronic bronchitis & emphysema) & associated dyspnoea. Spiriva Handihaler Prevention of exacerbations. Spiriva Respimat Improvement of COPD compromised quality of life & reduction of exacerbations. Add-on maintenance treatment for improvement of asthma symptoms, quality of life, & reduction of exacerbations in patients ≥6 yr w/ moderate to severe asthma who remain symptomatic on at least inhaled corticosteroids.
Dosage/Direction for Use
Spiriva Handihaler Inhale 1 cap once daily w/ the Handihaler at the same time of day. Spiriva Respimat Inhale 2 puffs of spray once daily at the same time of day.
Contraindications
History of hypersensitivity to atropine, or its derivatives eg, ipratropium or oxitropium.
Special Precautions
Immediate hypersensitivity reactions may occur. Not for initial treatment of acute episodes of bronchospasm. Do not use more frequently than once daily. Patients w/ narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction. Closely monitor patients w/ moderate to severe renal impairment (CrCl ≤50 mL/min). May cause inhalation-induced bronchospasm. Avoid contact w/ eyes. May influence ability to drive & use machinery. Pregnancy & lactation. Spiriva Handihaler Contains lactose. Spiriva Respimat Not for the relief of acute symptoms of bronchospasm; as 1st-line treatment for asthma.
Adverse Reactions
Dehydration; dizziness, insomnia; blurred vision, glaucoma, increased IOP; atrial fibrillation, supraventricular tachycardia, tachycardia, palpitations; cough, dysphonia, pharyngitis, bronchospasm, epistaxis, laryngitis, sinusitis; dry mouth (usually mild), constipation, GERD, oropharyngeal candidiasis, intestinal obstruction including ileus paralytic, dysphagia, gingivitis, glossitis, stomatitis; rash, hypersensitivity (including immediate reactions), pruritus, urticaria, dry skin, skin infection & ulcer; joint swelling; urinary retention (usually in men w/ predisposing factors), dysuria, UTI. Spiriva Handihaler: Angioedema. Spiriva Respimat: Angioneurotic oedema.
ATC Classification
R03BB04 - tiotropium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.
Presentation/Packing
Form
Spiriva Respimat soln for inhalation 2.5 mcg/puff
Packing/Price
60 puff x 1's
Form
Spiriva Handihaler inhalation powd cap 18 mcg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in